Castle Biosciences CEO Derek J. Maetzold sells $228,530.64 in shares
CSTL•Castle Biosciences President and CEO Derek J. Maetzold sold 6,942 common shares on Nov. 16, 2026, at $32.92 per share. He held no shares directly after the sales and retained 149,000 shares indirectly.
1. Share sale details
Maetzold sold 3,904 directly held shares and 3,038 trust-held shares. After the transactions, he held no common shares directly, while his indirect holdings totaled 149,000 common shares.




